Injury of Other Nerves at Wrist and Hand Level of Unspecified Arm, Initial Encounter

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Neuraptive Therapeutics
Neuraptive TherapeuticsPA - Chesterbrook
1 program
1
Polyethylene GlycolsPhase 11 trial
Active Trials
NCT03236064UnknownEst. May 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Neuraptive TherapeuticsPolyethylene Glycols

Clinical Trials (1)

NCT03236064Neuraptive TherapeuticsPolyethylene Glycols

Conversion of Seddon III Nerve Injury to Seddon I/II Nerve Injury

Start: May 2016Est. completion: May 2024
Phase 1Unknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space